The influence of the host microbiome on 3,4-methylenedioxymethamphetamine (MDMA)-induced hyperthermia and vice versa.
Animals
Fever
/ chemically induced
Hyperthermia, Induced
Male
Microbiota
/ drug effects
N-Methyl-3,4-methylenedioxyamphetamine
/ pharmacology
Proteus mirabilis
/ drug effects
Rats
Rats, Sprague-Dawley
Receptors, G-Protein-Coupled
/ metabolism
Uncoupling Protein 1
/ metabolism
Uncoupling Protein 3
/ metabolism
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 03 2019
13 03 2019
Historique:
received:
24
07
2018
accepted:
18
02
2019
entrez:
15
3
2019
pubmed:
15
3
2019
medline:
30
9
2020
Statut:
epublish
Résumé
Hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) can be life-threatening. Here, we investigate the role of the gut microbiome and TGR5 bile acid receptors in MDMA-mediated hyperthermia. Fourteen days prior to treatment with MDMA, male Sprague-Dawley rats were provided water or water treated with antibiotics. Animals that had received antibiotics displayed a reduction in gut bacteria and an attenuated hyperthermic response to MDMA. MDMA treated animals showed increased uncoupling protein 1 (UCP1) and TGR5 expression levels in brown adipose tissue and skeletal muscle while increased expression of UCP3 was observed only in skeletal muscle. Antibiotics prior to MDMA administration significantly blunted these increases in gene expression. Furthermore, inhibition of the TGR5 receptor with triamterene or of deiodinase II downstream of the TGR5 receptor with iopanoic acid also resulted in the attenuation of MDMA-induced hyperthermia. MDMA-treatment enriched the relative proportion of a Proteus mirabilis strain in the ceca of animals not pre-treated with antibiotics. These findings suggest a contributing role for the gut microbiota in MDMA-mediated hyperthermia and that MDMA treatment can trigger a rapid remodeling of the composition of the gut microbiome.
Identifiants
pubmed: 30867489
doi: 10.1038/s41598-019-40803-3
pii: 10.1038/s41598-019-40803-3
pmc: PMC6416279
doi:
Substances chimiques
Gpbar1 protein, rat
0
Receptors, G-Protein-Coupled
0
Uncoupling Protein 1
0
Uncoupling Protein 3
0
N-Methyl-3,4-methylenedioxyamphetamine
KE1SEN21RM
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4313Références
Neurotox Res. 2010 Aug;18(2):187-99
pubmed: 19777321
Nature. 2006 Jan 26;439(7075):484-9
pubmed: 16400329
J Pharmacol Exp Ther. 1995 Oct;275(1):325-33
pubmed: 7562567
Biochimie. 2017 Mar;134:93-98
pubmed: 27965179
Psychopharmacology (Berl). 2007 Jan;189(4):407-24
pubmed: 16541247
Thyroid. 2004 Mar;14(3):177-85
pubmed: 15072699
Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S162-4
pubmed: 10997646
Drug Des Devel Ther. 2017 Apr 05;11:1127-1134
pubmed: 28435224
Sci Rep. 2016 Oct 18;6:35455
pubmed: 27752130
Br J Pharmacol. 2002 Jan;135(1):170-80
pubmed: 11786492
J Neurosci. 2001 Nov 1;21(21):8648-54
pubmed: 11606652
Pharmacol Biochem Behav. 1991 Feb;38(2):339-44
pubmed: 1676171
J Neurosci. 1998 Jul 1;18(13):5086-94
pubmed: 9634574
J Pharmacol Exp Ther. 2007 Jan;320(1):274-80
pubmed: 17012607
Cell Metab. 2013 Feb 5;17(2):225-35
pubmed: 23395169
J Physiol. 2016 Dec 15;594(24):7455-7464
pubmed: 27647490
Nature. 2003 Nov 27;426(6965):403-4
pubmed: 14647371
J Biol Chem. 1997 Sep 26;272(39):24129-32
pubmed: 9305858
Diabetes. 2012 Nov;61(11):2753-62
pubmed: 22933116
J Lipid Res. 2006 Feb;47(2):241-59
pubmed: 16299351
Cell Metab. 2005 Aug;2(2):85-93
pubmed: 16098826
J Basic Clin Physiol Pharmacol. 1999;10(1):1-13
pubmed: 10392312
Nat Rev Microbiol. 2012 Nov;10(11):735-42
pubmed: 23000955
Biochem J. 1998 Jul 15;333 ( Pt 2):243-6
pubmed: 9657961
Gut Microbes. 2016 Jul 3;7(4):283-285
pubmed: 27148918
Front Neurosci. 2016 Sep 22;10:427
pubmed: 27713684
Microbiology (Reading). 2002 Jan;148(Pt 1):257-266
pubmed: 11782518
Psychopharmacology (Berl). 1994 Apr;114(3):505-8
pubmed: 7855209
Am J Physiol. 1990 Feb;258(2 Pt 2):R552-7
pubmed: 2309941
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1416-21
pubmed: 11171965
Compr Physiol. 2014 Oct;4(4):1677-713
pubmed: 25428857
Br J Pharmacol. 2007 Aug;151(7):1103-8
pubmed: 17533413
Cell. 2000 Sep 15;102(6):731-44
pubmed: 11030617
Neuroscience. 2007 Mar 16;145(2):764-74
pubmed: 17289273
Physiol Rev. 2004 Jan;84(1):277-359
pubmed: 14715917
Br J Pharmacol. 2007 Aug;151(7):1095-102
pubmed: 17592517
Neuropsychopharmacology. 2005 Jul;30(7):1312-23
pubmed: 15688085
Cell. 2015 Dec 3;163(6):1360-74
pubmed: 26638070
Eur J Pharmacol. 2008 Oct 31;596(1-3):84-8
pubmed: 18727928
Cell Metab. 2009 Sep;10(3):167-77
pubmed: 19723493
Med Clin North Am. 2005 Nov;89(6):1277-96
pubmed: 16227063
Curr Opin Gastroenterol. 2014 May;30(3):332-8
pubmed: 24625896
Psychopharmacology (Berl). 2005 Apr;178(4):505-13
pubmed: 15765263
Microbiome. 2018 Jun 8;6(1):103
pubmed: 29884232
J Intern Med. 2014 Jan;275(1):27-38
pubmed: 24118394
J Clin Invest. 1979 Jul;64(1):117-28
pubmed: 447848
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Appl Environ Microbiol. 2008 Mar;74(5):1469-77
pubmed: 18192423